Long Non-coding RNA UCA1 Enhances Cervical Cancer Cell Proliferation and Invasion by Regulating MicroRNA-299-3p Expression

Overview

Journal Oncol Lett

Specialty Oncology

Date 2021 Sep 30

PMID 34589151

Citations 6

Authors

Ming An

Xuefeng Xing

Tonghua Chen

Affiliations

Soon will be listed here.

Abstract

The long non-coding RNA, urothelial cancer-associated 1 (UCA1) is an important regulator in several tumors. However, to the best of our knowledge, the clinical roles of UCA1 in cervical cancer remain unclear. Thus, the present study aimed to investigate the function and mechanism of UCA1 in cervical cancer. Reverse transcription-quantitative PCR analysis was performed to detect UCA1 and microRNA (miR)-299-3p expression in cervical cancer tissues and cell lines. The Cell Counting Kit-8 and Transwell assays were performed to assess cell proliferation and invasion, respectively. Furthermore, the dual-luciferase reporter assay was performed to confirm the association between UCA1 and miR-299-3p. Rescue experiments were performed to determine the mechanism of the UCA1/miR-299-3p axis. The results demonstrated that UCA1 expression was upregulated in cervical cancer tissues and cell lines. Furthermore, overexpression of UCA1 enhanced the proliferation and invasion of cervical cancer cells, the effects of which were reversed following UCA1 knockdown. Notably, UCA1 interacted with miR-299-3p and negatively regulated miR-299-3p expression. In addition, miR-299-3p expression was downregulated in cervical cancer tissues and cell lines. Overexpression of miR-299-3p suppressed the proliferation and invasion of cervical cancer cells, reversing the effects of UCA1 knockdown on cervical cancer cell proliferation. Taken together, the results of the present study suggest that UCA1 promotes cell proliferation and invasion by regulating miR-299-3p expression in cervical cancer.

Citing Articles

LncRNA-miRNA-mRNA regulatory axes as potential biomarkers in cervical cancer: a comprehensive overview.

Patel D, Thankachan S, Sreeram S, Kavitha K, Kabekkodu S, Suresh P Mol Biol Rep. 2025; 52(1):110.

PMID: 39775991 DOI: 10.1007/s11033-024-10215-2.

CircVIRMA enhances cell malignant behavior by governing the miR-452-5p/CREBRF pathway in cervical cancer.

Hao C, Han J, Xiang K, Wang Y, Chen X, Yang C Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(11):8825-8838.

PMID: 38850300 DOI: 10.1007/s00210-024-03159-8.

The Role of Urothelial Cancer-Associated 1 in Gynecological Cancers.

Nousiopoulou E, Vrettou K, Damaskos C, Garmpis N, Garmpi A, Tsikouras P Curr Issues Mol Biol. 2024; 46(3):2772-2797.

PMID: 38534790 PMC: 10969036. DOI: 10.3390/cimb46030174.

Long non-coding RNAs PTENP1, GNG12-AS1, MAGI2-AS3 and MEG3 as tumor suppressors in breast cancer and their associations with clinicopathological parameters.

Zavesky L, Jandakova E, Weinberger V, Minar L, Kohoutova M, Slanar O Cancer Biomark. 2024; 40(1):61-78.

PMID: 38277283 PMC: 11191509. DOI: 10.3233/CBM-230259.

Serum LINC00152 and UCA1 in HCV-Induced Hepatocellular Carcinoma: Clinical Significance and Prognostic Value.

Shehab-Eldeen S, Essa A, Arafat E, Sleem A, Alhosary A, Darwish E Biologics. 2023; 17:137-149.

PMID: 37854341 PMC: 10581015. DOI: 10.2147/BTT.S433872.

References

Yan S, Chen M, Li G, Wang Y, Fan J . MiR-32 induces cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting PTEN. Tumour Biol. 2015; 36(6):4747-55. DOI: 10.1007/s13277-015-3124-9. View

Waggoner S . Cervical cancer. Lancet. 2003; 361(9376):2217-25. DOI: 10.1016/S0140-6736(03)13778-6. View

Pan S, Zhou H, Yu H, Xu L . MiR-195-5p inhibits the cell migration and invasion of cervical carcinoma through suppressing ARL2. Eur Rev Med Pharmacol Sci. 2019; 23(24):10664-10671. DOI: 10.26355/eurrev_201912_19764. View

Shen J, Zhang J, Xiao M, Yang J, Zhang N . miR-203 Suppresses Bladder Cancer Cell Growth and Targets Twist1. Oncol Res. 2017; 26(8):1155-1165. PMC: 7844766. DOI: 10.3727/096504017X15041934685237. View

Zhao J, Li L, Yang T . MiR-216a-3p suppresses the proliferation and invasion of cervical cancer through downregulation of ACTL6A-mediated YAP signaling. J Cell Physiol. 2020; 235(12):9718-9728. DOI: 10.1002/jcp.29783. View

Parkin D, Bray F, Ferlay J, Pisani P . Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55(2):74-108. DOI: 10.3322/canjclin.55.2.74. View

Gong Z, Zhang S, Zhang W, Huang H, Li Q, Deng H . Long non-coding RNAs in cancer. Sci China Life Sci. 2012; 55(12):1120-4. DOI: 10.1007/s11427-012-4413-9. View

Liu G, Wan Q, Li J, Hu X, Gu X, Xu S . Circ_0038467 regulates lipopolysaccharide-induced inflammatory injury in human bronchial epithelial cells through sponging miR-338-3p. Thorac Cancer. 2020; 11(5):1297-1308. PMC: 7180556. DOI: 10.1111/1759-7714.13397. View

Roik E, Sharashova E, Kharkova O, Nieboer E, Postoev V, Odland J . Sociodemographic characteristics, sexual behaviour and knowledge about cervical cancer prevention as risk factors for high-risk human papillomavirus infection in Arkhangelsk, North-West Russia. Int J Circumpolar Health. 2018; 77(1):1498681. PMC: 6060378. DOI: 10.1080/22423982.2018.1498681. View

10.

Shen S, Li K, Liu Y, Yang C, He C, Wang H . Silencing lncRNAs PVT1 Upregulates miR-145 and Confers Inhibitory Effects on Viability, Invasion, and Migration in EC. Mol Ther Nucleic Acids. 2020; 19:668-682. PMC: 6965729. DOI: 10.1016/j.omtn.2019.11.030. View

11.

Yu Y, Gao F, He Q, Li G, Ding G . lncRNA UCA1 Functions as a ceRNA to Promote Prostate Cancer Progression via Sponging miR143. Mol Ther Nucleic Acids. 2020; 19:751-758. PMC: 6962633. DOI: 10.1016/j.omtn.2019.11.021. View

12.

Wang R, Zuo X, Wang K, Han Q, Zuo J, Ni H . MicroRNA-485-5p attenuates cell proliferation in glioma by directly targeting paired box 3. Am J Cancer Res. 2019; 8(12):2507-2517. PMC: 6325470. View

13.

Agarwal R, Kaye S . Ovarian cancer: strategies for overcoming resistance to chemotherapy. Nat Rev Cancer. 2003; 3(7):502-16. DOI: 10.1038/nrc1123. View

14.

Luan Y, Li X, Luan Y, Zhao R, Li Y, Liu L . Circulating lncRNA UCA1 Promotes Malignancy of Colorectal Cancer via the miR-143/MYO6 Axis. Mol Ther Nucleic Acids. 2020; 19:790-803. PMC: 6970172. DOI: 10.1016/j.omtn.2019.12.009. View

15.

Li W, Zhang B, Jia Y, Shi H, Wang H, Guo Q . LncRNA LOXL1-AS1 regulates the tumorigenesis and development of lung adenocarcinoma through sponging miR-423-5p and targeting MYBL2. Cancer Med. 2019; 9(2):689-699. PMC: 6970024. DOI: 10.1002/cam4.2641. View

16.

Huang X, Liu X, Du B, Liu X, Xue M, Yan Q . LncRNA LINC01305 promotes cervical cancer progression through KHSRP and exosome-mediated transfer. Aging (Albany NY). 2021; 13(15):19230-19242. PMC: 8386557. DOI: 10.18632/aging.202565. View

17.

Wang Q, Yan S, Chu D, Xie Y, Wang C, Zhang J . Silencing of Long Non-coding RNA RP1-93H18.6 Acts as a Tumor Suppressor in Cervical Cancer through the Blockade of the PI3K/Akt Axis. Mol Ther Nucleic Acids. 2019; 19:304-317. PMC: 6938856. DOI: 10.1016/j.omtn.2019.10.041. View

18.

He X, Wang J, Chen J, Han L, Lu X, Miao D . lncRNA UCA1 Predicts a Poor Prognosis and Regulates Cell Proliferation and Migration by Repressing p21 and SPRY1 Expression in GC. Mol Ther Nucleic Acids. 2019; 18:605-616. PMC: 6839018. DOI: 10.1016/j.omtn.2019.09.024. View

19.

Sempere L, Christensen M, Silahtaroglu A, Bak M, Heath C, Schwartz G . Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res. 2007; 67(24):11612-20. DOI: 10.1158/0008-5472.CAN-07-5019. View

20.

Wang Y, Qin H . miR-338-3p targets and suppresses tumorigenicity of prostate cancer cells. Am J Cancer Res. 2019; 8(12):2564-2574. PMC: 6325485. View